6 days Ago By Defense World Staff
JPMorgan Chase & Co. cut its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 70.
9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 537,407 shares of the medical instruments supplier’s stock after selling 1,309,982 shares during the quarter. JPMorgan Chase & Co.
owned 0.27% of DENTSPLY SIRONA worth $10,200,000 as of its most recent filing with the Securities and Exchange Commission. A number of other institutional investors have also modified their holdings of the company.
Vanguard Group Inc. grew its position in DENTSPLY SIRONA by 0.3% in the 4th quarter.
Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier’s stock valued at $383,078,000 after acquiring an additional 65,478 shares in the last quarter. First Eagle Investment Management LLC boosted its stake in shares of DENTSPLY SIRONA by 2.
5% in the fourth quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier’s stock valued at $275,218,000 after purchasing an additional 348,532 shares during the period. Nuance Investments LLC grew its holdings in shares of DENTSPLY SIRONA by 25.
0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock valued at $257,103,000 after purchasing an additional 2,708,097 shares in the last quarter. Cooke & Bieler LP increased its stake in DENTSPLY SIRONA by 24.
3% during the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock worth $174,101,000 after buying an additional 1,794,391 shares during the period. Finally, Pacer Advisors Inc.
lifted its holdings in DENTSPLY SIRONA by 15,105.1% during the 4th quarter. Pacer Advisors Inc.
now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after buying an additional 4,473,972 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.
Insider ActivityIn other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was purchased at an average price of $16.
51 per share, for a total transaction of $249,994.42. Following the purchase, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.
21. This trade represents a 22.66 % increase in their ownership of the stock.
The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.52% of the company’s stock.
DENTSPLY SIRONA Stock Up 2.4 %DENTSPLY SIRONA stock opened at $13.08 on Tuesday.
The company has a market capitalization of $2.60 billion, a P/E ratio of -6.32, a PEG ratio of 1.
80 and a beta of 0.92. The company has a debt-to-equity ratio of 0.
72, a quick ratio of 0.84 and a current ratio of 1.25.
DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $31.
75. The stock has a 50-day simple moving average of $16.09 and a 200-day simple moving average of $19.
01. DENTSPLY SIRONA Announces DividendThe company also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were issued a $0.
16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.
89%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA’s payout ratio is currently -14.
07%. Analyst Upgrades and DowngradesSeveral research firms have commented on XRAY. Robert W.
Baird dropped their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research note on Friday, February 28th.
Evercore ISI reissued an “in-line” rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Wells Fargo & Company reduced their price target on DENTSPLY SIRONA from $20.
00 to $19.00 and set an “equal weight” rating on the stock in a research report on Friday, February 28th. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th.
Finally, StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Twelve research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company.
Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $23.33.Read Our Latest Report on XRAYDENTSPLY SIRONA Company Profile (Free Report)DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide.
It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.Featured StoriesFive stocks we like better than DENTSPLY SIRONA3 Dividend Kings To ConsiderWhy NVIDIA Stock Could Soar Despite Wall Street DowngradesIndustrial Products Stocks Investing Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldWith Risk Tolerance, One Size Does Not Fit All3 Hot New IPOs Defying the 2025 Market SlumpWant to see what other hedge funds are holding XRAY? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report)..
